SecSonar.com

OPKO Health, Inc. (OPK)

OPKO Health, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

OPKO Health, Inc. (OPK) is a Biotechnology company based in US with a market capitalization of $1.1B. Revenue declined 14.9% year-over-year and free cash flow was negative at -$190.8M. This page tracks OPK's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 3K employees · IPO Nov 2, 1995

Valuation

Valuation & price

$1.10 · as of May 17, 2026 · -30.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.89

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.58$1.34$1.10Jul 25Dec 25Jul 26Jul 7, 25$1.34Jul 9, 25$1.38Jul 11, 25$1.35Jul 15, 25$1.33Jul 17, 25$1.38Jul 21, 25$1.40Jul 23, 25$1.43Jul 25, 25$1.37Jul 29, 25$1.35Jul 31, 25$1.28Aug 4, 25$1.27Aug 6, 25$1.27Aug 11, 25$1.30Aug 13, 25$1.35Aug 15, 25$1.37Aug 19, 25$1.36Aug 21, 25$1.38Aug 25, 25$1.39Aug 27, 25$1.42Aug 29, 25$1.38Sep 3, 25$1.38Sep 5, 25$1.35Sep 9, 25$1.41Sep 11, 25$1.43Sep 16, 25$1.39Sep 18, 25$1.51Sep 22, 25$1.44Sep 24, 25$1.48Sep 26, 25$1.45Sep 30, 25$1.55Oct 2, 25$1.54Oct 6, 25$1.58Oct 8, 25$1.55Oct 10, 25$1.51Oct 14, 25$1.52Oct 16, 25$1.50Oct 21, 25$1.48Oct 23, 25$1.52Oct 27, 25$1.45Oct 29, 25$1.43Oct 31, 25$1.36Nov 4, 25$1.39Nov 6, 25$1.38Nov 10, 25$1.33Nov 12, 25$1.32Nov 14, 25$1.28Nov 18, 25$1.28Nov 20, 25$1.30Nov 25, 25$1.35Nov 28, 25$1.36Dec 2, 25$1.33Dec 4, 25$1.35Dec 8, 25$1.32Dec 10, 25$1.37Dec 12, 25$1.38Dec 16, 25$1.31Dec 18, 25$1.31Dec 22, 25$1.33Dec 24, 25$1.30Dec 29, 25$1.29Jan 2, 26$1.27Jan 6, 26$1.32Jan 8, 26$1.37Jan 12, 26$1.33Jan 14, 26$1.30Jan 16, 26$1.28Jan 21, 26$1.38Jan 23, 26$1.32Jan 27, 26$1.29Jan 29, 26$1.27Feb 2, 26$1.28Feb 4, 26$1.25Feb 9, 26$1.22Feb 11, 26$1.25Feb 13, 26$1.23Feb 18, 26$1.22Feb 20, 26$1.20Feb 24, 26$1.15Feb 26, 26$1.20Mar 2, 26$1.24Mar 4, 26$1.20Mar 6, 26$1.18Mar 10, 26$1.19Mar 12, 26$1.16Mar 17, 26$1.19Mar 19, 26$1.17Mar 23, 26$1.15Mar 25, 26$1.19Mar 27, 26$1.12Mar 31, 26$1.14Apr 2, 26$1.14Apr 7, 26$1.17Apr 9, 26$1.17Apr 13, 26$1.17Apr 15, 26$1.18Apr 17, 26$1.24Apr 22, 26$1.23Apr 24, 26$1.23Apr 28, 26$1.21Apr 30, 26$1.13May 4, 26$1.11May 6, 26$1.12May 8, 26$1.14May 12, 26$1.10May 14, 26$1.10May 18, 26$1.13May 20, 26$1.23May 22, 26$1.27May 28, 26$1.43Jun 1, 26$1.40Jun 3, 26$1.46Jun 5, 26$1.44Jun 9, 26$1.44Jun 11, 26$1.45Jun 15, 26$1.40Jun 17, 26$1.41Jun 22, 26$1.43Jun 24, 26$1.49Jun 26, 26$1.53Jul 2, 26$1.52
$1.1052-week range$1.58
Loading valuation history…

Fundamentals

Key fundamentals

$1.1B

Market cap

-14.9%

Revenue growth (YoY)

21.1%

Gross margin

-$190.8M

Free cash flow (USD)

$64.5M

Net debt

8.2%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.2BFY 2017$966.0MFY 2018$990.3MFY 2019$901.9MFY 2020$1.4BFY 2021$1.8BFY 2022$1.0BFY 2023$863.5MFY 2024$713.1MFY 2025$606.9M
$1.2B$606.9M

Free cash flow by year

2016 → 2025

FY 2016$8.5MFY 2017$-138.6MFY 2018$-137.0MFY 2019$-185.3MFY 2020$5.8MFY 2021$6.2MFY 2022$-119.8MFY 2023$-44.5MFY 2024$-208.5MFY 2025$-190.8M
$8.5M-$190.8M

Gross margin by year

2021 → 2025

FY 202132.8%FY 202228.7%FY 202336.8%FY 202443.6%FY 202521.1%
32.8%21.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 28, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 18, 2026Filing
  • 8-K eventEarnings ReleaseApr 28, 2026Filing
  • Quarterly report10-Q FiledApr 28, 2026Filing

Questions

Frequently asked questions

What is OPKO Health, Inc.'s market cap?

OPKO Health, Inc. (OPK) has a market capitalization of $1.1B.

What is OPK's P/E ratio?

A meaningful P/E ratio is not available for OPK — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is OPK's price-to-book (P/B) ratio?

OPK trades at 0.89 times book value per share.

Are insiders buying OPK stock?

SEC Form 4 filings show no open-market insider buys at OPKO Health, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ABSI

Absci Corporation

$1.1B

EYPT

EyePoint Pharmaceuticals, Inc.

$1.2B

AKTS

Aktis Oncology, Inc.

$1.1B

AMLX

Amylyx Pharmaceuticals, Inc.

$1.2B

MNKD

MannKind Corporation

$1.2B

XERS

Xeris Biopharma Holdings, Inc.

$1.1B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.